{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:02:54Z","timestamp":1791565374564,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["HEALTH-F2-2010-242193"],"award-info":[{"award-number":["HEALTH-F2-2010-242193"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40256-019-00375-z","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:32:04Z","timestamp":1572031924000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictors of Left Ventricular Dysfunction in Friedreich\u2019s Ataxia in a 16-Year Observational Study"],"prefix":"10.1007","volume":"20","author":[{"given":"Lise","family":"Legrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdourahmane","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Lorraine","family":"Monin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Ewenczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6622-2990","authenticated-orcid":false,"given":"Francoise","family":"Pousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"issue":"16","key":"375_CR1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C, Mandel JL, Brice A, Koenig M. Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia. N Engl J Med. 1996;335(16):1169\u201375.","journal-title":"N Engl J Med"},{"issue":"11","key":"375_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","volume":"72","author":"F Pousset","year":"2015","unstructured":"Pousset F, Legrand L, Monin ML, Ewenczyk C, Charles P, Komajda M, Brice A, Pandolfo M, Isnard R, Tezenas du Montcel S, Durr A. A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia. JAMA Neurol. 2015;72(11):1334\u201341.","journal-title":"JAMA Neurol"},{"issue":"3","key":"375_CR3","first-page":"554","volume":"59","author":"A Filla","year":"1996","unstructured":"Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G, Cocozza S. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996;59(3):554\u201360.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"375_CR4","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1161\/01.CIR.95.9.2247","volume":"95","author":"R Isnard","year":"1997","unstructured":"Isnard R, Kalotka H, Durr A, Cossee M, Schmitt M, Pousset F, Thomas D, Brice A, Koenig M, Komajda M. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich\u2019s ataxia. Circulation. 1997;95(9):2247\u20139.","journal-title":"Circulation"},{"issue":"2","key":"375_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pjnns.2018.02.003","volume":"52","author":"G Tai","year":"2018","unstructured":"Tai G, Corben LA, Yiu EM, Milne SC, Delatycki MB. Progress in the treatment of Friedreich ataxia. Neurol Neurochir Pol. 2018;52(2):129\u201339.","journal-title":"Neurol Neurochir Pol"},{"issue":"5","key":"375_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","volume":"20","author":"M Perdomini","year":"2014","unstructured":"Perdomini M, Belbellaa B, Monassier L, Reutenauer L, Messaddeq N, Cartier N, Crystal RG, Aubourg P, Puccio H. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia. Nat Med. 2014;20(5):542\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"375_CR7","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.ymthe.2018.05.006","volume":"26","author":"F Piguet","year":"2018","unstructured":"Piguet F, de Montigny C, Vaucamps N, Reutenauer L, Eisenmann A, Puccio H. Rapid and complete reversal of sensory ataxia by gene therapy in a novel model of Friedreich ataxia. Mol Ther. 2018;26(8):1940\u201352.","journal-title":"Mol Ther"},{"issue":"10","key":"375_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd.2018.158","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY. Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov. 2018;17(10):767.","journal-title":"Nat Rev Drug Discov"},{"issue":"1\u20132","key":"375_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","volume":"307","author":"AY Tsou","year":"2011","unstructured":"Tsou AY, Paulsen EK, Lagedrost SJ, Perlman SL, Mathews KD, Wilmot GR, Ravina B, Koeppen AH, Lynch DR. Mortality in Friedreich ataxia. J Neurol Sci. 2011;307(1\u20132):46\u20139.","journal-title":"J Neurol Sci"},{"key":"375_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijcard.2015.05.074","volume":"194","author":"F Weidemann","year":"2015","unstructured":"Weidemann F, Liu D, Hu K, Florescu C, Niemann M, Herrmann S, Kramer B, Klebe S, Doppler K, Uceyler N, Ritter CO, Ertl G, Stork S. The cardiomyopathy in Friedreich\u2019s ataxia\u2014new biomarker for staging cardiac involvement. Int J Cardiol. 2015;194:50\u20137.","journal-title":"Int J Cardiol"},{"issue":"3","key":"375_CR11","doi-asserted-by":"publisher","first-page":"e0122188","DOI":"10.1371\/journal.pone.0122188","volume":"10","author":"K Reetz","year":"2015","unstructured":"Reetz K, Abbas Z, Costa AS, Gras V, Tiffin-Richards F, Mirzazade S, Holschbach B, Frank RD, Vassiliadou A, Kruger T, Eitner F, Gross T, Schulz JB, Floege J, Shah NJ. Increased cerebral water content in hemodialysis patients. PLoS One. 2015;10(3):e0122188.","journal-title":"PLoS One"},{"issue":"13","key":"375_CR12","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S1474-4422(16)30287-3","volume":"15","author":"K Reetz","year":"2016","unstructured":"Reetz K, Dogan I, Hilgers RD, Giunti P, Mariotti C, Durr A, Boesch S, Klopstock T, de Rivera FJ, Schols L, Klockgether T, Burk K, Rai M, Pandolfo M, Schulz JB, EFACTS Study Group. Progression characteristics of the European Friedreich\u2019s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Lancet Neurol. 2016;15(13):1346\u201354.","journal-title":"Lancet Neurol"},{"issue":"12","key":"375_CR13","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, G. Chamber Quantification Writing Group, American Society of Echocardiography\u2019s Guidelines and Standards Committee, European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"375_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-7120-3-17","volume":"3","author":"M Foppa","year":"2005","unstructured":"Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy. Cardiovasc Ultrasound. 2005;3:17.","journal-title":"Cardiovasc Ultrasound"},{"issue":"14","key":"375_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787\u2013847.","journal-title":"Eur Heart J"},{"issue":"5","key":"375_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/01.CIR.62.5.1054","volume":"62","author":"WL Henry","year":"1980","unstructured":"Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980;62(5):1054\u201361.","journal-title":"Circulation"},{"issue":"13","key":"375_CR17","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","volume":"125","author":"F Weidemann","year":"2012","unstructured":"Weidemann F, Rummey C, Bijnens B, Stork S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T, Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) Study Group. The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation. 2012;125(13):1626\u201334.","journal-title":"Circulation"},{"issue":"3","key":"375_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00246-008-9305-1","volume":"30","author":"A Kipps","year":"2009","unstructured":"Kipps A, Alexander M, Colan SD, Gauvreau K, Smoot L, Crawford L, Darras BT, Blume ED. The longitudinal course of cardiomyopathy in Friedreich\u2019s ataxia during childhood. Pediatr Cardiol. 2009;30(3):306\u201310.","journal-title":"Pediatr Cardiol"},{"key":"375_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jns.2017.01.027","volume":"375","author":"A McCormick","year":"2017","unstructured":"McCormick A, Shinnick J, Schadt K, Rodriguez R, Addonizio L, Hirano M, Perlman S, Lin KY, Lynch DR. Cardiac transplantation in Friedreich ataxia: extended follow-up. J Neurol Sci. 2017;375:471\u20133.","journal-title":"J Neurol Sci"},{"issue":"12","key":"375_CR20","doi-asserted-by":"publisher","first-page":"e0189990","DOI":"10.1371\/journal.pone.0189990","volume":"12","author":"A Long","year":"2017","unstructured":"Long A, Napierala JS, Polak U, Hauser L, Koeppen AH, Lynch DR, Napierala M. Somatic instability of the expanded GAA repeats in Friedreich\u2019s ataxia. PLoS One. 2017;12(12):e0189990.","journal-title":"PLoS One"},{"key":"375_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","volume":"9","author":"LA Corben","year":"2014","unstructured":"Corben LA, Lynch D, Pandolfo M, Schulz JB, Delatycki MB, Clinical Management Guidelines Writing Group. Consensus clinical management guidelines for Friedreich ataxia. Orphanet J Rare Dis. 2014;9:184.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"375_CR22","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/ejechocard\/jer267","volume":"13","author":"C Dedobbeleer","year":"2012","unstructured":"Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P. Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich\u2019s ataxia. Eur Heart J Cardiovasc Imaging. 2012;13(4):346\u201352.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"375_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/echo.12287","volume":"31","author":"M St John Sutton","year":"2014","unstructured":"St John Sutton M, Ky B, Regner SR, Schadt K, Plappert T, He J, D\u2019souza B, Lynch DR. Longitudinal strain in Friedreich ataxia: a potential marker for early left ventricular dysfunction. Echocardiography. 2014;31(1):50\u20137.","journal-title":"Echocardiography"},{"issue":"14","key":"375_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","volume":"51","author":"AS Adabag","year":"2008","unstructured":"Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(14):1369\u201374.","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-019-00375-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-019-00375-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T23:29:56Z","timestamp":1603495796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-019-00375-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1007\/s40256-019-00375-z","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"25 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by FP7 (7th Framework Programme) Grant HEALTH-F2-2010-242193 from the European Commission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Lise Legrand, Abdourahmane Diallo, Marie-Lorraine Monin, Claire Ewenczyk, Perrine Charles, Richard Isnard, Eric Vicaut, Gilles Montalescot, Alexandra Durr, and Francoise Pousset declare that they have no potential conflicts of interest that might be relevant to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}